| Literature DB >> 25914873 |
Kevin Christopher1, Vishruti Makani1, Wesley Judy1, Erica Lee1, Nicholas Chiaia1, Dong Shik Kim2, Joshua Park1.
Abstract
Recently, some polysaccharides showed therapeutic potentials for the treatment of neurodegenerative diseases while the most important property, their permeability to the blood brain barrier (BBB) that sheathes the brain and spinal cord, is not yet determined. The determination has been delayed by the difficulty in tracking a target polysaccharide among endogenous polysaccharides in animal. We developed an easy way to examine the BBB-permeability and, possibly, tissue distribution of a target polysaccharide in animal. We tagged a polysaccharide with fluorescent 8-aminonaphthalene-1,3,6-trisulfonic acid disodium salt (ANTS) for tracking. We also developed a simple method to separate ANTS-tagged polysaccharide from unconjugated free ANTS using 75% ethanol. After ANTS-polysaccharide was intra-nasally administered into animals, we could quantify the amounts of ANTS-polysaccharide in the brain and the serum by fluorocytometry. We could also separate free ANTS-polysaccharide from serum proteins using trichloroacetic acid (TCA) and 75% ethanol. Our method will help to track a polysaccharide in animal easily. ANTS-labeling is less tedious than but as powerful as radiolabeling for tracking a target polysaccharide in animal.Our simple method can separate structurally intact ANTS-polysaccharide from animal serum and tissues.This method is good for the fluorometry-based measurement of ANTS-conjugated macromolecules in tissues.Entities:
Keywords: ANTS labeling; Blood brain barrier (BBB)-permeability; polysaccharide tracking
Year: 2015 PMID: 25914873 PMCID: PMC4407278 DOI: 10.1016/j.mex.2015.03.006
Source DB: PubMed Journal: MethodsX ISSN: 2215-0161
Fig. 1(A) The standard curve of emissions at 520 nm (relative fluorescence unit: RFU) of ANTS at 0, 0.1, 0.3, 1, 3, and 10 mM (n = 5). (B) The standard curve of absorbances at 490 nm for 0, 7.4, and 74 nM, 0.74 and 7.4 mM of midi-GAGR (n = 3). (C) Fluorescent and colorimetric values of ANTS-midi-GAGR before and after three 75% ethanol washes (Mean ± Std. Error, n = 5).
Fig. 2(A) The standard curve of emission at 520 nm of ANTS in the sera at 0, 0.01, 0.03, 0.1 and 0.3 mM (n = 3). (B) The calculated concentrations (Mean ± Std. Error) of midi-GAGR in the sera at 6 h after the intranasal administration of ANTS-midi-GAGR (n = 3). (C) The standard curve of emission at 520 nm of ANTS in the brain cytosol at 0, 0.01, 0.03, 0.1, and 0.3 mM (n = 3). (D) The calculated concentrations (Mean ± Std. Error) of midi-GAGR in the different brain regions at 6 and 24 h after the intranasal administration of ANTS-midi-GAGR (n = 3). (E) The RFUs (Mean ± Mean ± Std. Error) of the supernatants and pellets of TCA precipitation and ethanol precipitation of sera (n = 5).